documents: FDA-2020-D-1825-0017
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2020-D-1825-0017 | FDA | FDA-2020-D-1825 | Investigational COVID-19 Convalescent Plasma; Guidance for Industry | Other | Guidance | 2022-01-10T05:00:00Z | 2022 | 1 | 2022-01-10T05:00:00Z | 2022-01-10T14:52:32Z | 0 | 0 | 0900006484f1672e |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref